Cargando…

Ring Expansion Leads to a More Potent Analogue of Ipomoeassin F

[Image: see text] Two new ring-size-varying analogues (2 and 3) of ipomoeassin F were synthesized and evaluated. Improved cytotoxicity (IC(50): from 1.8 nM) and in vitro protein translocation inhibition (IC(50): 35 nM) derived from ring expansion imply that the binding pocket of Sec61α (isoform 1) c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zong, Guanghui, Hu, Zhijian, Duah, Kwabena Baffour, Andrews, Lauren E., Zhou, Jianhong, O’Keefe, Sarah, Whisenhunt, Lucas, Shim, Joong Sup, Du, Yuchun, High, Stephen, Shi, Wei Q.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808706/
https://www.ncbi.nlm.nih.gov/pubmed/33264019
http://dx.doi.org/10.1021/acs.joc.0c01659
_version_ 1783636958627495936
author Zong, Guanghui
Hu, Zhijian
Duah, Kwabena Baffour
Andrews, Lauren E.
Zhou, Jianhong
O’Keefe, Sarah
Whisenhunt, Lucas
Shim, Joong Sup
Du, Yuchun
High, Stephen
Shi, Wei Q.
author_facet Zong, Guanghui
Hu, Zhijian
Duah, Kwabena Baffour
Andrews, Lauren E.
Zhou, Jianhong
O’Keefe, Sarah
Whisenhunt, Lucas
Shim, Joong Sup
Du, Yuchun
High, Stephen
Shi, Wei Q.
author_sort Zong, Guanghui
collection PubMed
description [Image: see text] Two new ring-size-varying analogues (2 and 3) of ipomoeassin F were synthesized and evaluated. Improved cytotoxicity (IC(50): from 1.8 nM) and in vitro protein translocation inhibition (IC(50): 35 nM) derived from ring expansion imply that the binding pocket of Sec61α (isoform 1) can accommodate further structural modifications, likely in the fatty acid portion. Streamlined preparation of the key diol intermediate 5 enabled gram-scale production, allowing us to establish that ipomoeassin F is biologically active in vivo (MTD: ∼3 mg/kg).
format Online
Article
Text
id pubmed-7808706
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-78087062021-01-15 Ring Expansion Leads to a More Potent Analogue of Ipomoeassin F Zong, Guanghui Hu, Zhijian Duah, Kwabena Baffour Andrews, Lauren E. Zhou, Jianhong O’Keefe, Sarah Whisenhunt, Lucas Shim, Joong Sup Du, Yuchun High, Stephen Shi, Wei Q. J Org Chem [Image: see text] Two new ring-size-varying analogues (2 and 3) of ipomoeassin F were synthesized and evaluated. Improved cytotoxicity (IC(50): from 1.8 nM) and in vitro protein translocation inhibition (IC(50): 35 nM) derived from ring expansion imply that the binding pocket of Sec61α (isoform 1) can accommodate further structural modifications, likely in the fatty acid portion. Streamlined preparation of the key diol intermediate 5 enabled gram-scale production, allowing us to establish that ipomoeassin F is biologically active in vivo (MTD: ∼3 mg/kg). American Chemical Society 2020-12-02 2020-12-18 /pmc/articles/PMC7808706/ /pubmed/33264019 http://dx.doi.org/10.1021/acs.joc.0c01659 Text en © 2020 American Chemical Society This is an open access article published under a Creative Commons Attribution (CC-BY) License (http://pubs.acs.org/page/policy/authorchoice_ccby_termsofuse.html) , which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.
spellingShingle Zong, Guanghui
Hu, Zhijian
Duah, Kwabena Baffour
Andrews, Lauren E.
Zhou, Jianhong
O’Keefe, Sarah
Whisenhunt, Lucas
Shim, Joong Sup
Du, Yuchun
High, Stephen
Shi, Wei Q.
Ring Expansion Leads to a More Potent Analogue of Ipomoeassin F
title Ring Expansion Leads to a More Potent Analogue of Ipomoeassin F
title_full Ring Expansion Leads to a More Potent Analogue of Ipomoeassin F
title_fullStr Ring Expansion Leads to a More Potent Analogue of Ipomoeassin F
title_full_unstemmed Ring Expansion Leads to a More Potent Analogue of Ipomoeassin F
title_short Ring Expansion Leads to a More Potent Analogue of Ipomoeassin F
title_sort ring expansion leads to a more potent analogue of ipomoeassin f
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808706/
https://www.ncbi.nlm.nih.gov/pubmed/33264019
http://dx.doi.org/10.1021/acs.joc.0c01659
work_keys_str_mv AT zongguanghui ringexpansionleadstoamorepotentanalogueofipomoeassinf
AT huzhijian ringexpansionleadstoamorepotentanalogueofipomoeassinf
AT duahkwabenabaffour ringexpansionleadstoamorepotentanalogueofipomoeassinf
AT andrewslaurene ringexpansionleadstoamorepotentanalogueofipomoeassinf
AT zhoujianhong ringexpansionleadstoamorepotentanalogueofipomoeassinf
AT okeefesarah ringexpansionleadstoamorepotentanalogueofipomoeassinf
AT whisenhuntlucas ringexpansionleadstoamorepotentanalogueofipomoeassinf
AT shimjoongsup ringexpansionleadstoamorepotentanalogueofipomoeassinf
AT duyuchun ringexpansionleadstoamorepotentanalogueofipomoeassinf
AT highstephen ringexpansionleadstoamorepotentanalogueofipomoeassinf
AT shiweiq ringexpansionleadstoamorepotentanalogueofipomoeassinf